Sally Chapman

1.0k total citations
19 papers, 472 citations indexed

About

Sally Chapman is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Sally Chapman has authored 19 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 2 papers in Surgery. Recurrent topics in Sally Chapman's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Sarcoidosis and Beryllium Toxicity Research (9 papers) and Occupational and environmental lung diseases (4 papers). Sally Chapman is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Sarcoidosis and Beryllium Toxicity Research (9 papers) and Occupational and environmental lung diseases (4 papers). Sally Chapman collaborates with scholars based in Australia, United Kingdom and New Zealand. Sally Chapman's co-authors include Ian Glaspole, Nicole Goh, Paul N. Reynolds, Yuben Moodley, Tamera J. Corte, Samantha Ellis, E. Haydn Walters, Sacha Macansh, Annabelle Mahar and Christopher Zappala and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and European Respiratory Journal.

In The Last Decade

Sally Chapman

19 papers receiving 464 citations

Peers

Countries citing papers authored by Sally Chapman

Since Specialization

Citations

This map shows the geographic impact of Sally Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Chapman more than expected).

Fields of papers citing papers by Sally Chapman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Chapman. The network helps show where Sally Chapman may publish in the future.

Co-authorship network of co-authors of Sally Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Chapman. A scholar is included among the top collaborators of Sally Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Chapman. Sally Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients 2025 ·Respirology ·(unknown), Dino B.A. Tan, (unknown), Wendy A. Cooper, Helen E. Jo, Christopher Grainge, Ian Glaspole, Nicole Goh, Samantha Ellis, Peter Hopkins, Christopher Zappala, Gregory J. Keir, Paul N. Reynolds, Sally Chapman, E. Haydn Walters, Darryl A. Knight, Svetlana Baltic, HuiJun Chih, Tamera J. Corte, Yuben Moodley	2
2	Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision 2024 ·Respirology ·John A. Mackintosh, Gregory J. Keir, Lauren Troy, Anne E. Holland, Christopher Grainge, Daniel C. Chambers, (unknown), Helen E. Jo, Ian Glaspole, Margaret Wilsher, Nicole Goh, Paul N. Reynolds, Sally Chapman, Steven E. Mutsaers, (unknown), Susanne Webster, Yuben Moodley, Tamera J. Corte	26
3	Anti‐tumour necrosis factor‐α‐induced lupus in a patient receiving infliximab for sarcoidosis 2022 ·SHILAP Revista de lepidopterología ·(unknown), Sally Chapman	1
4	Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis 2022 ·Respirology ·Stephen M. Humphries, John A. Mackintosh, Helen E. Jo, Simon Walsh, Mario Silva, Lucio Calandriello, Sally Chapman, Samantha Ellis, Ian Glaspole, Nicole Goh, Christopher Grainge, Peter Hopkins, Gregory J. Keir, Yuben Moodley, Paul N. Reynolds, E. Haydn Walters, David Baraghoshi, Athol U. Wells, David A. Lynch, Tamera J. Corte	41
5	Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry 2019 ·BMC Pulmonary Medicine ·Helen E. Jo, Tamera J. Corte, Ian Glaspole, Christopher Grainge, Peter Hopkins, Yuben Moodley, Paul N. Reynolds, Sally Chapman, E. Haydn Walters, Christopher Zappala, Heather Allan, Gregory J. Keir, Wendy A. Cooper, Annabelle Mahar, Samantha Ellis, Sacha Macansh, Nicole Goh	22
6	Does face-to-face pre-operative joint replacement education reduce hospital costs in a regional Australian hospital? A descriptive retrospective clinical audit 2019 ·European Journal of Orthopaedic Surgery & Traumatology ·(unknown), (unknown), (unknown), Sally Chapman, Anestis Divanoglou, Christopher M. Doran, (unknown), (unknown), Luke Heales	6
7	Adult Cystic Fibrosis (CF) patients prefer to perform impulse oscillometry (IOS) in comparison to spirometry 2019 ·(unknown), (unknown), Sally Chapman, Emily Hopkins, Judith Morton	1
8	Eligibility for anti‐fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing 2019 ·Respirology ·(unknown), (unknown), John D. Brannan, John Attia, Kerrin Palazzi, Christopher Oldmeadow, Tamera J. Corte, Ian Glaspole, Nicole Goh, Gregory J. Keir, Heather Allan, Sally Chapman, Wendy A. Cooper, Samantha Ellis, Peter Hopkins, Yuben Moodley, Paul N. Reynolds, Christopher Zappala, Sacha Macansh, Christopher Grainge	5
9	Is impulse oscillometry (IOS) better than spirometry for monitoring treatment outcomes in adult cystic fibrosis (CF) pulmonary exacerbations? A pilot study 2019 ·(unknown), Judith Morton, Sally Chapman, Emily Hopkins, Chien‐Li Holmes‐Liew, (unknown)	1
10	Invasive tracheal aspergillosis after chemoradiotherapy treatment 2019 ·Respirology Case Reports ·(unknown), Phan Nguyen, Sally Chapman	4
11	Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry 2018 ·BMC Pulmonary Medicine ·Helen E. Jo, Ian Glaspole, Yuben Moodley, Sally Chapman, Samantha Ellis, Nicole Goh, Peter Hopkins, (unknown), Annabelle Mahar, Wendy A. Cooper, Paul N. Reynolds, E. Haydn Walters, Christopher Zappala, Christopher Grainge, Heather Allan, Sacha Macansh, Tamera J. Corte	55
12	Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry 2017 ·European Respiratory Journal ·Helen E. Jo, Ian Glaspole, Christopher Grainge, Nicole Goh, Peter Hopkins, Yuben Moodley, Paul N. Reynolds, Sally Chapman, E. Haydn Walters, Christopher Zappala, Heather Allan, Gregory J. Keir, Andrew Hayen, Wendy A. Cooper, Annabelle Mahar, Samantha Ellis, Sacha Macansh, Tamera J. Corte	161
13	Health‐related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry 2017 ·Respirology ·Ian Glaspole, Sally Chapman, Wendy A. Cooper, Samantha Ellis, Nicole Goh, Peter Hopkins, Sacha Macansh, Annabelle Mahar, Yuben Moodley, Eldho Paul, Paul N. Reynolds, E. Haydn Walters, Christopher Zappala, Tamera J. Corte	82
14	Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia 2017 ·Respirology ·Helen E. Jo, Lauren Troy, Gregory J. Keir, Daniel C. Chambers, Anne E. Holland, Nicole Goh, Margaret Wilsher, (unknown), Yuben Moodley, Christopher Grainge, Helen Whitford, Sally Chapman, Paul N. Reynolds, Ian Glaspole, (unknown), (unknown), Peter Hopkins, Tamera J. Corte	33
15	Disease progression at 12 months does not predict future outcomes in IPF patients: Analysis from the Australian IPF Registry 2017 ·Helen E. Jo, Ian Glaspole, Christopher Grainge, Nicole Goh, Peter Hopkins, Yuben Moodley, Paul N. Reynolds, Sally Chapman, E. Haydn Walters, Christopher Zappala, Heather Allan, Gregory J. Keir, Andrew Hayen, Wendy A. Cooper, Annabelle Mahar, Samantha Ellis, Sacha Macansh, Tamera J. Corte	1
16	Disease progression in early idiopathic pulmonary fibrosis: Insights from the Australian IPF registry 2016 ·Helen E. Jo, Ian Glaspole, Yuben Moodley, Sally Chapman, Wendy A. Cooper, Samantha Ellis, Nicole Goh, Peter Hopkins, (unknown), Annabelle Mahar, Paul N. Reynolds, E. Haydn Walters, Christopher Zappala, Christopher Grainge, Heather Allan, Tamera J. Corte	1
17	Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us? 2015 ·Ian Glaspole, Nicole Goh, Peter Hopkins, Yuben Moodley, Paul N. Reynolds, E. Haydn Walters, Christopher Zappala, Heather Allan, Sally Chapman, Wendy A. Cooper, Samantha Ellis, Annabelle Mahar, (unknown), Richard N. Henson, Sacha Macansh, Sarah Richards, Susan Smith, Karen Symons, Eldho Paul, Tamera J. Corte	3
18	Current Australasian practice for diagnosis and management of idiopathic pulmonary fibrosis: Where are we now? 2015 ·Respirology ·Lauren Troy, Sally Chapman, Fiona Lake, Margaret Wilsher, (unknown), Sacha Macansh, Tamera J. Corte	9
19	Unilateral Diaphragmatic Paralysis Following Bronchial Artery Embolization for Hemoptysis 2000 ·CHEST Journal ·Sally Chapman, Mark Holmes, (unknown)	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact